MHLW Approves Pfizer’s Pneumococcal Vaccine, New H5N1 Influenza Vaccine in Japan
This article was originally published in PharmAsia News
Executive Summary
Japan’s MHLW approved a new pneumococcal vaccine produced by Pfizer and an H5N1 vaccine produced by Takeda.